← Back to Clinical Trials
Recruiting NCT06841887

New Advanced Vascular Imaging Ultrasound Protocols

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Renal Diseases
Sponsor Mario Negri Institute for Pharmacological Research
Study Type OBSERVATIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2025-05-09
Completion 2027-03
Interventions
US acquisitions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is a single-center observational study aimed at setting up and testing new ultrasound vascular imaging protocols, conducted exclusively for research purposes. The study will perform US examinations in 60 subjects. The subjects enrolled in the study will be examined the first time and will then provide consent to be examined again in the future if needed. The primary aim of this study is to set-up and test new advanced US protocol for the arm and cerebral blood vessels The secondary objectives will be: * Define ranges of normality/reference values of US-based parameters to be compared with pathological values. * Evaluate the repeatability and reproducibility of the acquired US measurements. * Evaluate the correlation between age and the acquired US measurements. * Evaluate the correlation between gender and the acquired US measurements.

Eligibility Criteria

Inclusion Criteria: * Provision of informed consent prior to any study specific procedures * Female and/or male aged between 18 and 75 years * No previous history of kidney or cerebral disease and no pathologies that might have affected the vascular system Exclusion Criteria: * Previous history of kidney or cerebral disease or pathologies that might have affected the vascular system * Legal incapacity, limited legal capacity, intellectual disability, uncooperative attitude or any other evidence that the subject will not be able to understand the study aims and procedures

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}